sponsored links

Metformin reduces overall cancer risk in patients with Type 2 diabetes

Sponsored Links

A commonly prescribed diabetes drug, metformin , reduces the overall cancer risk in people with Type 2 diabetes , a large systematic review study finds.

View full post on Mexico News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.